Star Combo Pharma Ltd
Research Star Combo Pharma Ltd (S66) on Bullrun: market cap AUD 17.56M, P/E 3.3, dividend yield 2.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerS66
- ExchangeAU
- CountryAustralia
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- CurrencyAUD
- Market capAUD 17.56M
- P/E3.3
- Dividend yield2.6%
- Financial periodFY2025
Valuation Snapshot
latest market cap is AUD 17.56M; P/E is 3.3; dividend yield is 2.6%.
Peer valuation comparison
Latest P/E is 3.25x versus a Consumer Defensive sector median of 17.41x (81.3% below).
Latest dividend yield is 2.64% versus a Consumer Defensive sector median of 3.04% (13.2% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | 0.04 | n/a | n/a | n/a |
| FY2024 | AUD 26.02M | AUD 747.33K | -AUD 1.76M | 28.5% | 0.01 | AUD 7.36M | AUD 4.03M | AUD 33.32M |
| FY2023 | AUD 24.70M | -AUD 4.00M | -AUD 851.83K | 21.8% | -0.03 | AUD 9.49M | AUD 4.19M | AUD 33.09M |
| FY2022 | AUD 22.88M | -AUD 696.35K | -AUD 6.76M | 24.5% | -0.01 | AUD 10.39M | AUD 4.12M | AUD 35.41M |
| FY2021 | AUD 26.72M | -AUD 7.88M | -AUD 6.93M | 17.2% | n/a | AUD 17.32M | AUD 3.30M | AUD 36.19M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | AUD 17.56M | 3.3 | 2.9% | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD, yield 2.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0 AUD |
| FY2024 | 0 AUD |
About Star Combo Pharma Ltd
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its products under the Costar, Living Healthy, Amax, and J&K brands.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Star Combo Pharma Ltd's market cap?
Star Combo Pharma Ltd's market capitalization is AUD 17.56M.
What is Star Combo Pharma Ltd's P/E ratio?
Star Combo Pharma Ltd's price-to-earnings (P/E) ratio is 3.3.
Does Star Combo Pharma Ltd pay a dividend?
Star Combo Pharma Ltd has a dividend yield of 2.6%.
What does Star Combo Pharma Ltd do?
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its products under the Costar, Living Healthy, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.